Heather A. Halem,Michael DeWitt Culler,Andrew A. Butler
申请号：
US15242866
公开号：
US09827286B2
申请日:
2016.08.22
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as insulin resistance.
